Stocks · Healthcare · Medical - Care Facilities
PACS Group, Inc. PACS
$42.71 -0.33% Close, Oct 5, 2026 · NYSE · Market cap $6.78B
Strong trendInexpensive vs sector
Next earnings report: Nov 9, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $1.67, up 103.7% year over year.
- Over the past year the stock returned +202.3%, ahead of the S&P 500 by 186.5 percentage points.
- Net debt is 6.4× EBITDA, a high level of leverage.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 39%
- EPS growth (TTM, YoY)Top 11%
- FCF growth (TTM, YoY)Top 27%
- Revenue growth, 3-year CAGRTop 22%
- Revenue growth accelerationBottom 23%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 22%
- Gross marginBottom 14%
- Operating marginTop 31%
- Cash conversion (OCF / net income)Top 29%
- Accruals (lower is better)Bottom 44%
- Net debt / EBITDA (lower is better)Bottom 10%
- Interest coverTop 13%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 14%
- Free-cash-flow yieldTop 13%
- EBITDA / enterprise valueTop 23%
- Sales / enterprise valueTop 22%
- P/E vs own 5-year history (lower is better)Top 34%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 6%
- 6-month returnTop 32%
- 1-year return vs S&P 500Top 5%
- Distance from 52-week highTop 23%
- Trend checklist (0–4)Top 26%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 41%
- Consecutive EPS beatsTop 35%
- Share of analysts rating BuyTop 10%
- Upside to consensus price targetBottom 36%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 15%
- Maximum drawdown, 3 yearsBottom 29%
- Beta vs S&P 500 (lower is better)Top 1%
- Net debt / EBITDA (lower is better)Bottom 10%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 20.9% | 15.2% | ↓ |
| EPS growth (YoY) | 245.5% | 103.7% | ↓ |
| Gross margin | 17.0% | 19.7% | ↑ |
| Operating margin | 4.6% | 7.4% | ↑ |
| FCF margin | 6.0% | 8.2% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 15.2% | 20.9% | ↓ | Top 39% |
| EPS growth (TTM, YoY) | 103.7% | 245.5% | ↓ | Top 11% |
| Gross margin | 19.7% | 17.0% | ↑ | Bottom 14% |
| Operating margin | 7.4% | 4.6% | ↑ | Top 31% |
| Net margin | 4.8% | 2.7% | ↑ | — |
| Free-cash-flow margin | 8.2% | 6.0% | ↑ | — |
| Return on invested capital | 6.1% | — | Top 22% | |
| Revenue growth, 3-year CAGR | 29.7% | — | Top 22% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 2.13×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -5.4%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1.3%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -10.2 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 6.43×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 13.9×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 0.01%
- Shareholder yield
- 0.01%
- Share count change, 1 year
- -2.1%
- Share count change, 3-year CAGR
- +2.6%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 4, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 2
- Beats in the last 8 reports
- 4 of 8
- Average EPS surprise, last 4
- -0.2%
- Average 2-day reaction, last 8
- +2.7%
- Positive 20 days after report
- 2 of 8
Analysts
- Consensus price target
- $56.67
- Target vs current price
- +32.7%
- Analysts with a rating
- 8
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | +17.3% | +0.7% | +8.9% | -4.9% | — |
| May 11, 2026 | +19.0% | -5.0% | +11.6% | +4.4% | +35.9% |
| Feb 26, 2026 | -10.4% | +6.0% | -7.5% | -17.0% | -3.9% |
| Nov 19, 2025 | -26.7% | +16.6% | +120.2% | +140.3% | +184.2% |
| Aug 18, 2025 | +42.5% | -0.8% | +4.8% | -9.3% | +8.7% |
| May 19, 2025 | -0.9% | -1.5% | -9.2% | -6.2% | +6.2% |
| Feb 26, 2025 | -1.2% | -1.9% | -4.5% | -15.7% | -26.7% |
| Nov 8, 2024 | +2.9% | +7.6% | -7.1% | -21.8% | -28.5% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | $0.63 | $0.54 | +17.3% | $1.43B |
| May 11, 2026 | $0.50 | $0.42 | +19.0% | $1.42B |
| Feb 26, 2026 | $0.43 | $0.48 | -10.4% | $1.36B |
| Nov 19, 2025 | $0.33 | $0.45 | -26.7% | $1.34B |
| Aug 18, 2025 | $0.56 | $0.39 | +42.5% | $1.31B |
| May 19, 2025 | $0.42 | $0.42 | -0.9% | $1.10B |
| Feb 26, 2025 | $0.39 | $0.40 | -1.2% | $1.04B |
| Nov 8, 2024 | $0.35 | $0.34 | +2.9% | $995.2M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 25.6× | 28.7× | 27th | Top 14% |
| P/E (forward) | 18.0× | — | — | — |
| EV / EBITDA | 20.6× | — | — | Top 23% |
| EV / Sales | 1.78× | — | — | Top 22% |
| Free-cash-flow yield | 6.72% | — | — | Top 13% |
| Earnings yield | 3.91% | — | — | Top 14% |
P/E over the past five years
Range 16.2× – 52.4× since Dec 31, 2023. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- +202.3%
- Earnings per share growth (TTM)
- +103.7%
- Change in P/E multiple
- +30.8%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✗ Price above 50-day average
- ✓ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 221
- 50-day average slope (20 days)
- -1.5%
- 200-day average slope (20 days)
- +3.3%
- Distance from 50-day average
- -2.8%
- Distance from 200-day average
- +9.5%
- RSI (14)
- 50.1
- Relative volume
- 1.05×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 34.5%
- Volatility vs own 5-year history
- 6th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- -0.25
- Correlation with S&P 500
- -0.03
- Current drawdown from 1-year high
- -11.8%
- Maximum drawdown, 3 years
- -82.0%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Nov 1, 2024 | Sep 10, 2025 | -82.0% | 212 days | 202 days (Jul 1, 2026) |
| Aug 10, 2026 | Oct 1, 2026 | -15.3% | 37 days | Not yet recovered |
| Aug 26, 2024 | Sep 4, 2024 | -11.6% | 6 days | 11 days (Sep 19, 2024) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $6.78B
- P/E (TTM)
- 25.6
- EPS, diluted (TTM)
- $1.67
- Revenue (TTM)
- $5.55B
- 52-week range
- $10.31 – $49.49
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.17B | $2.42B | $3.11B | $4.09B | $5.29B |
| Gross profit | $187.3M | $400.7M | $447.1M | $792.6M | $1.16B |
| Operating income | $83.4M | $229.4M | $207.8M | $123.1M | $309.6M |
| Net income | $47.9M | $150.5M | $112.9M | $55.8M | $191.5M |
| EPS (diluted) | $0.32 | $1.00 | $0.75 | $0.38 | $1.22 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.03B | $1.21B | $1.28B | $1.31B | $1.34B | $1.36B | $1.42B | $1.43B |
| Net income | $15.6M | $37.2M | $28.5M | $51.0M | $52.4M | $59.7M | $80.7M | $76.4M |
| EPS (diluted) | $0.10 | $0.24 | $0.17 | $0.31 | $0.32 | $0.38 | $0.50 | $0.47 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $57.6M | $92.6M | $63.7M | $367.3M | $404.2M |
| Capital expenditure | -$124.1M | -$22.9M | -$45.8M | -$349.8M | -$105.4M |
| Free cash flow | -$66.5M | $69.8M | $17.9M | $17.5M | $298.8M |
| Dividends paid | -$53.8M | -$60.3M | -$80.4M | -$33.7M | $0 |
| Net share buybacks | $0 | $0 | $0 | $509.4M | $0 |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $164.5M
- Total assets
- $5.66B
- Total liabilities
- $4.54B
- Total debt
- $3.25B
- Net debt
- $3.09B
- Shareholders’ equity
- $1.11B
As of Jun 30, 2026 (filed Aug 4, 2026).
Short interest
- Shares sold short
- 3,740,748
- Days to cover
- 5.30
- Change vs previous report
- +12.4%
FINRA short interest, settlement date Sep 15, 2026.